Vistin Pharma ASA represents a strong commitment to integrity, quality, and innovation in the pharmaceutical industry. With a focus on providing reliable and high-quality products, the company strives to deliver value to patients, customers, and shareholders alike. Vistin Pharma ASA's corporate philosophy emphasizes ethical business practices, strict adherence to regulatory standards, and a customer-centric approach. By combining cutting-edge technology with a dedicated team of experts, Vistin Pharma ASA aims to improve and advance global healthcare while creating sustainable value for its stakeholders.

Vistin Pharma ASA is primarily present in Norway.

Vistin Pharma ASA, a leading pharmaceutical company, has accomplished several significant milestones. The company successfully achieved a significant increase in its production capacity and revenue, resulting in substantial growth over the years. Vistin Pharma ASA also expanded its market presence by entering into strategic partnerships and collaborations with renowned industry players. They have consistently delivered high-quality pharmaceutical products and achieved regulatory approvals for various drugs. Moreover, Vistin Pharma ASA has consistently focused on research and development, leading to successful product innovations and advancements. These milestones highlight their commitment to excellence and position them as a prominent player in the pharmaceutical industry.

Vistin Pharma ASA is a pharmaceutical company based in Norway. Founded in 2015, the company specializes in the production and development of high-quality active pharmaceutical ingredients (APIs) for the global market. With state-of-the-art manufacturing facilities and strict quality standards, Vistin Pharma ASA has established itself as a trusted supplier in the pharmaceutical industry. The company's history is marked by continuous growth and innovation, driven by a team of experienced professionals dedicated to delivering safe and effective medication solutions. Vistin Pharma ASA's commitment to excellence has helped it build a strong reputation and forge partnerships with leading healthcare providers worldwide.

Vistin Pharma ASA faces competition from several prominent players in the market. Some of its major competitors include established pharmaceutical companies such as Pfizer, Merck, Novartis, and Sanofi. These global players have a wide range of products and a strong market presence, making them direct competitors for Vistin Pharma ASA. Additionally, there are other smaller pharmaceutical companies operating in the same therapeutic areas, which also pose competition to Vistin Pharma ASA. Surviving and thriving in this competitive landscape requires Vistin Pharma ASA to continuously innovate, develop high-quality products, and differentiate itself through effective marketing strategies.

Vistin Pharma ASA is primarily active in the pharmaceutical industry.

Vistin Pharma ASA operates as a specialty pharmaceutical company. Their business model focuses on the development, production, and commercialization of active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs) for the global pharmaceutical industry. Vistin Pharma specializes in the production of metformin, a widely used oral anti-diabetic drug. With a strong emphasis on quality and compliance, Vistin Pharma aims to provide high-quality pharmaceutical products to help improve the lives of patients worldwide. As a leading player in the API market, Vistin Pharma's business model revolves around delivering reliable and efficient solutions to pharmaceutical companies, contributing to the overall health and well-being of individuals.

Il P/E per Vistin Pharma A non può essere attualmente calcolato.

L'indicatore Price-to-Sales (KUV) per Vistin Pharma A non può essere calcolato al momento.

Il Quality Score AlleAktien per Vistin Pharma A è 4/10.

Il fatturato non può essere attualmente calcolato per Vistin Pharma A.

Il profitto per Vistin Pharma A non può essere attualmente calcolato.

Vistin Pharma ASA is a Norwegian pharmaceutical company that specializes in the development, production, and marketing of pharmaceutical active ingredients for use in medications. The company operates in two main business areas: Pharmaceutical active ingredients and citric acid. The core business of Vistin Pharma ASA is the production of pharmaceutical active ingredients. The company manufactures a variety of active ingredients that can be used to treat various diseases. These include antibiotics, painkillers, antidepressants, and medications for the treatment of cardiovascular diseases. Vistin Pharma is an important supplier of pharmaceutical active ingredients to the global pharmaceutical industry and works closely with customers to develop customized solutions. The second business area of Vistin Pharma is citric acid production. This is an important raw material for the food and beverage industry as well as the chemical industry. Citric acid production takes place in Norway and Germany. Citric acid is used as an acidifier in food and beverages and serves as a catalyst in the production of chemicals and pharmaceuticals. Vistin Pharma produces high-quality citric acid that meets the highest quality standards. The company is committed to continuously improving its production processes and being innovative. Vistin Pharma strives to meet the requirements of its customers while also finding long-term and sustainable solutions. Vistin Pharma's customers include some of the largest pharmaceutical companies in the world. The company is dedicated to building close relationships with its customers and offering them customized solutions. Vistin Pharma aims to be a leading provider of pharmaceutical active ingredients and citric acid. The company has a clear growth strategy and is focused on diversification and expansion into new markets. Overall, Vistin Pharma has established itself as a leading company in the pharmaceutical and chemical industry. The company strives to offer high-quality products and provide its customers with excellent service. With its innovation, quality standards, and strong customer orientation, Vistin Pharma will continue to play an important role in the industry.

Vistin Pharma A distribuisce un dividendo di 0,75 NOK suddiviso in pagamenti all'anno.

La dividendazione per Vistin Pharma A non può essere attualmente calcolata oppure la società non distribuisce dividendi.

La ISIN di Vistin Pharma A è NO0010734122.

Il codice WKN di Vistin Pharma A è A14TLR.

Il ticker di Vistin Pharma A è VISTN.OL.

Nell'ultimo anno, Vistin Pharma A ha pagato un dividendo di 0,75 NOK . Questo corrisponde a un rendimento da dividendo di circa 2,87 %. Per i prossimi 12 mesi, Vistin Pharma A prevede di pagare un dividendo di 0,75 NOK.

La resa dei dividendi di Vistin Pharma A è attualmente del 2,87 %.

Vistin Pharma A paga un dividendo su base trimestrale. Questo viene distribuito nei mesi di giugno, febbraio, luglio, dicembre.

Vistin Pharma A ha pagato un dividendo ogni anno negli ultimi 0 anni.

Nei prossimi 12 mesi si prevedono dividendi per un importo di 0,75 NOK. Questo corrisponde a un rendimento da dividendo del 2,87 %.

Vistin Pharma A è assegnato al settore 'Salute'.

Per ricevere l'ultima dividend of Vistin Pharma A del 19/11/2024 dell'importo di 0,5 NOK, dovevi avere l'azione in portafoglio prima del giorno "Ex" il 06/11/2024.

La distribuzione dell'ultima dividenda è avvenuta il 19/11/2024.

Nell'anno 2023 sono stati distribuiti da Vistin Pharma A 0,5 NOK come dividendi.

Le dividende di Vistin Pharma A vengono distribuite in NOK.